The leading Complicated Urinary Tract Infection Companies such as Spero Therapeutics, Iterum Therapeutics, Venatorx Pharmaceuticals Inc., Nabriva Therapeutics, Allecra Therapeutics, Wockhardt, MerLion ...

Sepsis risk models for resistant gram-negative infections vary by hospital and patient group, highlighting the need for local ...

Ahmedabad: A recent study has raised alarm bells about the growing resistance of typhoid-causing bacteria to several ...

For the detection of resistance phenotypes, the antibiotics used were: amoxicillin-clavulanic acid (20/10 μg), ceftriaxone (30 μg), cefepime (30 μg), ertapenem (10 μg), aztreonam (30 μg), ...

For bloodstream infections caused by chromosomal AmpC β-lactamase-producing strains, cefepime may be an appropriate carbapenem-sparing treatment option. Cefepime is supported as an alternative to ...

Review the side-effects of Cefepime as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Further information Decision makers have concluded that this technology will not progress as a potential technology appraisal or a highly specialised technology. Traditional approaches to ...

Orchid Pharma Limited recently announced the launch of its new drug – Cefepime-Enmetazobactam, which has been approved for the treatment of complicated Urinary Tract infections (cUTI), Hospital ...

Orchid Pharma Limited, a Chennai-based Indian pharmaceutical company, announced the launch of its new drug - cefepime-enmetazobactam, which has been approved for the treatment of complicated urinary ...

The United States regulator has signed off on Allecra Therapeutics’ Exblifep (cefepime/enmatazobactam) as a treatment for cUTIs, including the severe kidney condition pyelonephritis, brought on ...

Everest Medicines ‘s licensing partner, Venatorx Pharmaceuticals announced that The New England Journal of Medicine published the results of the CERTAIN-1 Phase 3 clinical study of the investigational ...